1. Cell Cycle/DNA Damage Apoptosis
  2. Nucleoside Antimetabolite/Analog Apoptosis
  3. RX-3117

RX-3117  (Synonyms: TV-1360; Fluorocyclopentenylcytosine)

目录号: HY-15228 纯度: ≥98.0%
COA 产品使用指南

RX-3117 (TV-1360) 是一种有效的口服活性抗癌和抗代谢物药剂。RX-3117 抑制 DNA 甲基转移酶 1 (DNMT1。RX-3117 显示出抗增殖和抗肿瘤活性。RX-3117 诱导细胞周期停滞在 S 期和细胞凋亡 (apoptosis)。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

我们将采用定制合成服务的方式为您快速提供所需产品和技术服务

RX-3117 Chemical Structure

RX-3117 Chemical Structure

CAS No. : 865838-26-2

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 价格 是否有货 数量
10 mM * 1 mL in DMSO ¥3850
In-stock
1 mg ¥1600
In-stock
2 mg ¥2300
In-stock
5 mg ¥3500
In-stock
10 mg ¥5000
In-stock
50 mg 询价

* Please select Quantity before adding items.

Customer Review

MCE 顾客使用本产品发表的 1 篇科研文献

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

RX-3117 (TV-1360) is a potent and orally active anticancer and antimetaboliteagent. RX-3117 inhibits DNA methyltransferase 1 (DNMT1). RX-3117 shows antiproliferative and anti-tumour activity. RX-3117 induces cell cycle arrest at S phase and apoptosis[1][2][3].

细胞效力
(Cellular Effect)
Cell Line Type Value Description References
A549 IC50
0.5 μM
Compound: 5a
Antitumor activity against human A549 cells by SRB method
Antitumor activity against human A549 cells by SRB method
[PMID: 22524616]
HCT-116 IC50
0.19 μM
Compound: 5a
Antitumor activity against human HCT116 cells by SRB method
Antitumor activity against human HCT116 cells by SRB method
[PMID: 22524616]
HeLa IC50
1.35 μM
Compound: 5a
Antitumor activity against human HeLa cells by SRB method
Antitumor activity against human HeLa cells by SRB method
[PMID: 22524616]
HepG2 IC50
0.79 μM
Compound: 5a
Antitumor activity against human HepG2 cells by SRB method
Antitumor activity against human HepG2 cells by SRB method
[PMID: 22524616]
HT-29 IC50
0.28 μM
Compound: 5a
Antitumor activity against human HT-29 cells by SRB method
Antitumor activity against human HT-29 cells by SRB method
[PMID: 22524616]
K562 IC50
0.82 μM
Compound: 5a
Antitumor activity against human K562 cells by SRB method
Antitumor activity against human K562 cells by SRB method
[PMID: 22524616]
LNCaP IC50
2.67 μM
Compound: 5a
Antitumor activity against human LNCAP cells by SRB method
Antitumor activity against human LNCAP cells by SRB method
[PMID: 22524616]
MCF7 IC50
0.34 μM
Compound: 5a
Antitumor activity against human MCF7 cells by SRB method
Antitumor activity against human MCF7 cells by SRB method
[PMID: 22524616]
MDA-MB-231 IC50
0.18 μM
Compound: 5a
Antitumor activity against human MDA-MB-231 cells by SRB method
Antitumor activity against human MDA-MB-231 cells by SRB method
[PMID: 22524616]
MKN-45 IC50
0.34 μM
Compound: 5a
Antitumor activity against human MKN45 cells by SRB method
Antitumor activity against human MKN45 cells by SRB method
[PMID: 22524616]
NCI-H226 IC50
0.25 μM
Compound: 5a
Antitumor activity against human NCI-H226 cells by SRB method
Antitumor activity against human NCI-H226 cells by SRB method
[PMID: 22524616]
OVCAR-3 IC50
0.8 μM
Compound: 5a
Antitumor activity against human OVCAR3 cells by SRB method
Antitumor activity against human OVCAR3 cells by SRB method
[PMID: 22524616]
PANC-1 IC50
0.62 μM
Compound: 5a
Antitumor activity against human PANC1 cells by SRB method
Antitumor activity against human PANC1 cells by SRB method
[PMID: 22524616]
PC-3 IC50
0.63 μM
Compound: 5a
Antitumor activity against human PC3 cells by SRB method
Antitumor activity against human PC3 cells by SRB method
[PMID: 22524616]
SK-MEL-28 IC50
1.38 μM
Compound: 5a
Antitumor activity against human SK-MEL-28 cells by SRB method
Antitumor activity against human SK-MEL-28 cells by SRB method
[PMID: 22524616]
U-251 IC50
0.83 μM
Compound: 5a
Antitumor activity against human U251 cells by SRB method
Antitumor activity against human U251 cells by SRB method
[PMID: 22524616]
体外研究
(In Vitro)

RX-3117 抑制 DNA 和 RNA 合成[1]
RX-3117 (11.7,21 μM;48 小时) 在 A549、SW1573 细胞中表现出抗增殖活性[1]
RX-3117 被尿苷胞苷激酶 2 (UCK2) 激活[1]
RX-3117 (1-25 μM;72 h) 抑制 HCT-116、MDA-MB-231、PANC-1、Caki-1、MCF7、A549、MKN45、U251 细胞的生长,IC50 分别为 0.39、0.18、0.62,分别为 0.84、0.34、0.34、0.50、0.83 μM[2]
RX-3117 (5、10 μM;4 天) 诱导细胞周期停滞在 S 期和细胞凋亡[2]
RX-3117 (1-5 μM;24 小时) 在 MDA-MB-231 中以剂量依赖性方式降低 DNMT1 的细胞量[3]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay[1]

Cell Line: A549, SW1573 cells
Concentration: 11.7, 21 µM
Incubation Time: 48 h
Result: Showed antiproliferative activity in A549 (63.7% cell growth), SW1573 cells (59% cell growth).

Apoptosis Analysis[2]

Cell Line: A549, SW1573 NSCLC cells
Concentration: 5 µM for A549 cells, 10 µM for SW1573 cells
Incubation Time: 4 days
Result: Induced cell cycle arrest at S phase and apoptosis.
体内研究
(In Vivo)

RX-3117 (2,10 mg/kg;腹腔注射;每周 3 次,持续 5 周) 在裸鼠体内显示出抗肿瘤活性[3]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Nude mice (human colon carcinoma HCT116 xenograft model)[3]
Dosage: 2, 10 mg/kg
Administration: I.p.; three times per week for five weeks
Result: Caused significant inhibition of tumor growth at the doses of 2 and 10 mg/kg.
Clinical Trial
分子量

257.22

Formula

C10H12FN3O4

CAS 号
性状

固体

颜色

White to off-white

中文名称

氟环戊烯基胞嘧啶

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 2 years
-20°C 1 year
溶解性数据
细胞实验: 

DMSO 中的溶解度 : ≥ 50 mg/mL (194.39 mM; 吸湿的 DMSO 对产品的溶解度有显著影响,请使用新开封的 DMSO)

* "≥" means soluble, but saturation unknown.

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 3.8877 mL 19.4386 mL 38.8772 mL
5 mM 0.7775 mL 3.8877 mL 7.7754 mL
查看完整储备液配制表

* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 2 years; -20°C, 1 year。-80°C储存时,请在2年内使用, -20°C储存时,请在1年内使用。

  • 摩尔计算器

  • 稀释计算器

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量
=
浓度
×
体积
×
分子量 *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start)

C1

×
体积 (start)

V1

=
浓度 (final)

C2

×
体积 (final)

V2

动物溶解方案计算器
请输入动物实验的基本信息:

给药剂量

mg/kg

动物的平均体重

g

每只动物的给药体积

μL

动物数量

由于实验过程有损耗,建议您多配一只动物的量
计算结果
工作液所需浓度 : mg/mL
纯度 & 产品资料
参考文献

完整储备液配制表

* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 2 years; -20°C, 1 year。-80°C储存时,请在2年内使用, -20°C储存时,请在1年内使用。

可选溶剂 浓度 溶剂体积 质量 1 mg 5 mg 10 mg 25 mg
DMSO 1 mM 3.8877 mL 19.4386 mL 38.8772 mL 97.1931 mL
5 mM 0.7775 mL 3.8877 mL 7.7754 mL 19.4386 mL
10 mM 0.3888 mL 1.9439 mL 3.8877 mL 9.7193 mL
15 mM 0.2592 mL 1.2959 mL 2.5918 mL 6.4795 mL
20 mM 0.1944 mL 0.9719 mL 1.9439 mL 4.8597 mL
25 mM 0.1555 mL 0.7775 mL 1.5551 mL 3.8877 mL
30 mM 0.1296 mL 0.6480 mL 1.2959 mL 3.2398 mL
40 mM 0.0972 mL 0.4860 mL 0.9719 mL 2.4298 mL
50 mM 0.0778 mL 0.3888 mL 0.7775 mL 1.9439 mL
60 mM 0.0648 mL 0.3240 mL 0.6480 mL 1.6199 mL
80 mM 0.0486 mL 0.2430 mL 0.4860 mL 1.2149 mL
100 mM 0.0389 mL 0.1944 mL 0.3888 mL 0.9719 mL
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
RX-3117
目录号:
HY-15228
需求量: